Anti-C5a antibody IFX-1 (vilobelimab) treatment versus best supportive care for patients with severe COVID-19 (PANAMO): an exploratory, open-label, phase 2 randomised controlled trial
Resource Type
Article
Authors
Vlaar, Alexander P J ; de Bruin, Sanne ; Busch, Matthias ; Timmermans, Sjoerd A M E G ; van Zeggeren, Ingeborg E ; Koning, Rutger ; ter Horst, Liora ; Bulle, Esther B ; van Baarle, Frank E H P ; van de Poll, Marcel C G ; Kemper, E Marleen ; van der Horst, Iwan C C ; Schultz, Marcus J ; Horn, Janneke ; Paulus, Frederique ; Bos, Lieuwe D ; Wiersinga, W Joost ; Witzenrath, Martin ; Rueckinger, Simon ; Pilz, Korinna ; Brouwer, Matthijs C ; Guo, Ren-Feng ; Heunks, Leo ; van Paassen, Pieter ; Riedemann, Niels C ; van de Beek, Diederik
Source
In The Lancet Rheumatology December 2020 2(12):e764-e773
Subject
Primary Research Articles
Language
ISSN
2665-9913